| 1 |
31930546 | Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment. | 2020 Mar |
2 |
| 2 |
31307523 | APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC. | 2019 Jul 15 |
2 |
| 3 |
31564904 | MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression. | 2019 |
1 |
| 4 |
31578585 | Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy. | 2019 Dec |
2 |
| 5 |
27813497 | Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients. | 2016 Nov 22 |
4 |
| 6 |
26164266 | APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER. | 2015 Sep |
1 |
| 7 |
24729390 | Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients. | 2014 Dec 1 |
1 |
| 8 |
25107571 | Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy. | 2014 Oct |
5 |
| 9 |
23479135 | Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer. | 2013 May |
1 |
| 10 |
19787261 | Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. | 2009 Nov |
4 |